We are live on ! Find out more
FOLD

Amicus Therapeutics
FOLD

Delisted

FOLD was delisted on the 24th of April, 2026.

Back to rankings

69 hedge funds and large institutions have $81.1M invested in Amicus Therapeutics in 2013 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 22 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

357% more call options, than puts

Call options by funds: $274K | Put options by funds: $60K

17% more capital invested

Capital invested by funds: $69.6M → $81.1M (+$11.5M)

5% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 22

4% less funds holding

Funds holding: 72 → 69 (-3)

27% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 11

Holders
69
Holders Change
-3
Holders Change %
-4.17%
% of All Funds
2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
23
Reduced
22
Closed
11
Calls
$274K
Puts
$60K
Net Calls
+$214K
Net Calls Change
-$627K

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$13.6M
2
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO)
California
+$424K
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$411K
4
HVC
Healthcare Value Capital
New Jersey
+$252K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$217K

Top Sellers

Rank Fund Capital Flow
1
PAI
Palo Alto Investors
California
-$1.35M
2
BFA
BlackRock Fund Advisors
California
-$1.28M
3
TC
TFS Capital
Pennsylvania
-$1.02M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$483K
5
First Manhattan
First Manhattan
New York
-$355K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$356K +$9.63K +4,388 +3%
TCIM
27
TIAA CREF Investment Management
New York
$290K – – –
BCM
28
Bridgeway Capital Management
Texas
$285K -$255K -115,991 -49%
California Public Employees Retirement System
29
California Public Employees Retirement System
California
$249K -$1.98K -900 -0.8%
Axa
30
Axa
France
$222K +$10.5K +4,767 +5%
BIM
31
BlackRock Investment Management
Delaware
$209K +$959 +437 +0.5%
AllianceBernstein
32
AllianceBernstein
Tennessee
$193K -$29.4K -13,400 -14%
CS
33
Credit Suisse
Switzerland
$183K +$42.3K +19,264 +33%
Charles Schwab
34
Charles Schwab
California
$130K – – –
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$129K – – –
PRHC
36
P.R. Herzig & Co
New York
$125K – – –
Goldman Sachs
37
Goldman Sachs
New York
$123K -$43.4K -19,778 -27%
TA
38
Teachers Advisors
New York
$106K – – –
Dimensional Fund Advisors
39
Dimensional Fund Advisors
Texas
$93K -$23K -10,500 -21%
Nomura Holdings
40
Nomura Holdings
Japan
$88K +$4.86K +2,212 +6%
WAM
41
Wolverine Asset Management
Illinois
$86K +$81.2K +37,000 New
LMF
42
LMR Master Fund
Cayman Islands
$81K +$75.4K +34,354 New
DS
43
DRW Securities
Illinois
$79K +$73.7K +33,593 New
Brown Advisory
44
Brown Advisory
Maryland
$75K – – –
Connor, Clark & Lunn Investment Management (CC&L)
45
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$69K +$19.1K +8,700 +46%
Jacobs Levy Equity Management
46
Jacobs Levy Equity Management
New Jersey
$68K -$233K -106,134 -79%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$67K – – –
DekaBank Deutsche Girozentrale
48
DekaBank Deutsche Girozentrale
Germany
$66K +$2.19K +1,000 +4%
SIP
49
Stoneridge Investment Partners
Pennsylvania
$59K +$878 +400 +2%
BA
50
BlackRock Advisors
Delaware
$59K +$8.73K +3,976 +19%
1
2
3 4

FOLD Hedge Fund Activity: Q4 2013 in Review

69 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q4 2013, worth a combined $81.1M — up 17% from $69.6M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of FOLD and 8 opened new positions — a net loss of 3 holders — while 22 trimmed existing stakes and 23 added.

The largest buyer was Redmile Group, adding an estimated $13.6M. The largest seller was Palo Alto Investors, cutting an estimated $1.35M.

  • 69 institutional investors held Amicus Therapeutics (FOLD) as of Q4 2013, down from 72 in Q3 2013.
  • Funds reported $81.1M of Amicus Therapeutics stock for Q4 2013, up 17% quarter-over-quarter.
  • 8 funds opened new Amicus Therapeutics positions in Q4 2013 and 11 closed out, a net change of -3 holders.
  • The largest Amicus Therapeutics buyer in Q4 2013 was Redmile Group, an estimated $13.6M added.
  • The largest Amicus Therapeutics seller in Q4 2013 was Palo Alto Investors, an estimated $1.35M sold.

Based on aggregated 13F filings for Q4 2013.